What are Antibiotic (conventional/established classes) drugs?

Antibiotic (conventional/established classes) drugs are pharmacologic agents that share a common mechanism. 1 are currently marketed, with 3 more in clinical development.

What are the marketed Antibiotic (conventional/established classes) drugs?

Marketed Antibiotic (conventional/established classes) drugs include conventional IP antibiotics.

Antibiotic (conventional/established classes)

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

1 marketed 3 in Phase 3

This page covers all Antibiotic (conventional/established classes) drugs tracked by Drug Landscape: marketed products and active clinical-stage compounds.

Marketed (1)

conventional IP antibiotics · Alice Ho Miu Ling Nethersole Hospital · Infectious Disease
Conventional IP antibiotics inhibit bacterial protein synthesis or cell wall integrity through established mechanisms, thereby killing or stopping the growth of susceptible bacteria.

Phase 3 pipeline (3)

Conventional drugs · University of Science and Technology, Yemen · Cardiovascular
This drug works by inhibiting the action of a specific enzyme.
Conventional Synthetic DMARD · SetPoint Medical Corporation · Immunology
Conventional synthetic DMARDs suppress immune system activity through inhibition of inflammatory pathways to reduce joint inflammation and slow disease progression in rheumatoid arthritis.
Non-Biologic DMARDs · Hoffmann-La Roche · Immunology / Rheumatology
Non-biologic DMARDs are small-molecule drugs that suppress the immune system to reduce inflammation and slow disease progression in rheumatoid arthritis and other autoimmune conditions.

Patent intelligence

conventional patent landscape — aggregated cliff calendar, attackable patents, originator estates